To Spot it Earlier

Nov 30, 2020

The National Health Service is to conduct a trial of a blood-based screening test to detect cancer before any signs of the disease crop up, the Guardian reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Recent Headlines from
Precision Oncology News

Sutro Biopharma Advancing STRO-002 in Phase I Trial With Eye on Biomarker Strategies
Premium
MMRF, Dana Farber Amassing Data to Develop Smoldering Multiple Myeloma Monitoring Test
Premium
MSK Researchers Chip Away at TMB Unknowns, Clarify Role in Predicting Immunotherapy Benefit
Premium
Ariz Precision Medicine Bets on a New Class of Cancer Drugs Targeting PRDM Genes
Premium
Precision Oncology in 2020: Pandemic Lessons, Biomarker Controversies, Community Access Gaps
Premium

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Menu